News

Cure for type 1 diabetes and key results of the dt-report.

Time in tight range, vision for AID, and obesity management.

Key innovations, screening, and fully-closed loop approaches.

Recent reports of unreliable continuous glucose monitoring (CGM) systems highlight the urgent need for European standards to ensure the quality of these devices.

Harmonising recommendations on the management of hyperglycaemic crises

Fixed-ratio combinations of basal insulin and GLP-1 receptor agonists (GLP-1 RA) have shown robust results as a treatment intensification option for people with type 2 diabetes.

The management of diabetic foot ulcers is a significant challenge, with amputation often being a necessary consequence. A novel approach using intact fish skin grafts, commonly used for burn wounds, has show...

Physical activity poses many challenges to people living with type 1 diabetes. A recently published position statement offers practical recommendations for the use of automated insulin delivery (AID) systems...

Kidney transplant recipients with type 1 diabetes who also receive an islet transplant profit from a significant reduction in the risk of death and the likelihood of returning to dialysis, a recent study sho...

In 1974, the International Society for Pediatric and Adolescent Diabetes (ISPAD) was founded as a professional organisation to promote science, research, education and advocacy in childhood and adolescent di...

In a recent randomised controlled trial, a whole-food, plant-based diet and exercise intervention was superior to standard medical care in improving glycaemic control, promoted diabetes remission and reduced...

A new consensus report offers key insights from over 6,000 articles on diabetic ketoacidosis and hyperglycaemic hyperosmolar state published since the previous 2009 consensus statement. Here we summarise how...

Cardiologists are increasingly interested in advances in diabetology, especially the latest drug classes, reports Tina Vilsbøll from a joint session of the European Association for the Study of Diabet...

The global burden of diabetes is continually growing, which calls for enhanced collective action to prevent and treat diabetes complications. The Sri Lanka College of Endocrinology, the European Association ...

The FLOW trial brought GLP-1 receptor agonists (GLP-1 RAs) to the forefront of the discussion about chronic kidney disease and type 2 diabetes. A new subanalysis now sheds light on the concomitant use of GLP...

The recently published Clinical Practice Guidelines on metabolic dysfunction-associated steatotic liver disease (MASLD) was a joint effort of the European Association for the Study of the Liver (EASL), the E...

People living with diabetes have to make hundreds of decisions each day to manage their disease. Diabetes technology promises to ease this burden, but how effective is it in practice? This was one of the que...

Artificial intelligence is going to revolutionise also the medical field, especially when it comes to harnessing existing data sets for practical applications. A Swedish consortium has now published its appr...

The final day of the 84th ADA Scientific Sessions has arrived. In our final Newsflash episode, Alice Cheng reviews major advances and discoveries in diabetes in the year gone by.

Incretin-based therapies are our focus in the Day 3 Newsflash from the 84th ADA Scientific Sessions. Ildiko Lingvay discusses their role in preventing the progression from prediabetes to diabetes. Michael Na...

A priority to focus on in people with newly diagnosed type 2 diabetes is remission, says Roy Taylor in the Newsflash from Day 2 of the ADA Scientific Sessions, emphasising the current international consensus.